Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Big Pharma and Nextleaf Solutions

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 13, 2021 11:45am

116 Views

Post# 32285064

RE:RE:RE:RE:RE:RE:RE:Big Pharma and Nextleaf Solutions

Nextleaf is pumping out a bunch of NR's before Jan 28 to offset the disappointing financials. Its stock is going to take a hit.

Lemoyne wrote: Exactly lol, they are late to the party. LABS has big pharma in its pocket already (It's a done deal), products shipping increasing. With its capabilities, it will snatch more big pharma CpG contracts before OILS gets its first local finished product contract.

OILS can't even produce finished products. It'll take money and time to get licenses and production lines/ tweaking those lines. by that time, LABS will be shipping millions of products every quarter.

Did I mention OILS is gonna have to dilute soon to be able to invest in licenses/ production lines? I think it's great time for OILS to dilute massively before Q4 earnings which might be a disaster considering the stock price hike it jusd had.

There goes their initial business plan (OILS) to be an extractor, they are realizing there is no growth there, 2 years late.